Latham & Watkins Advises Astorg and OPEN Health in Acquisition of Acsel Health

OPEN Health, a pre-eminent global provider of scientific communications and HEOR & market access services and a portfolio company of European private equity firm Astorg, has announced the acquisition of Acsel Health, a New York-based life science strategy and advisory firm focused on commercial strategy, pricing and market access, and commercial excellence.

Latham & Watkins LLP represented Astorg and OPEN Health in the transaction with a corporate deal team led by New York partner David Beller and New York counsel Edmond Parhami, with associates Daniel Weissman, Brent Begany, and London partners Thomas Forschbach and Maarten Overmars, with associates Antonina Semyachkova and Cécile Wirxel. Advice was also provided on tax matters by New York partner Eric Kamerman and Boston partner Brian McManus, with associate Lukas Kutilek; on private equity finance matters by New York partner Josh Tinkelman, with associate Chen Tang; on healthcare regulatory matters by Washington, D.C. counsel Betty Pang; on benefits and compensation matters by Washington, D.C. partner Adam Kestenbaum, with associate Dan Gocek; on intellectual property matters by New York counsel Carrie Girgenti, with associate Alan Kim; on data privacy matters by Bay Area partner Heather Deixler; on real estate matters by New York counsel Shira Bressler; on environmental matters by New York counsel David Langer; on antitrust matters by Washington, D.C. partners Mandy Reeves and Katherine Rocco, Washington, D.C. counsel Britton Davis, and Brussels counsel Tomas Nilsson, with associates Carla Palma and Rebecca Frumento; on CFIUS matters by Washington, D.C. partner Jim Barker; on sanctions matters by Washington, D.C. partner Les Carnegie, with associate Matthew Gregory; and on insurance matters by Los Angeles partner Drew Levin, with associate Harrison White.